ViroGates A/S revised earnings guidance for full-year 2022 and 2023. For the period, the company expects revenue of approximately DKK 10 million in 2022 (previously DKK 10 to 13 million) and EBIT of approximately DKK -11 million in 2022 (previously DKK -11 to -14 million).

For the year 2023, the company expects revenue between DKK 14 to 17 million in 2023 (previously DKK 17 to 21 million) due to less COVID-19 testing expected next year and EBIT of approximately DKK -8 to -11 million in 2023 (previously no guidance).